Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025Angela Rose, European IVE group, Kimberly Marsh et al.|Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)|2025Cited by 0